enlightenVue
Pre-clinicalThe SurgiVue platform enables both diagnostic and therapeutic interventions in a single procedure based on the endoscope industry’s smallest working diameter (2mm) with two working channels and flush ports, along with superior optics. Other key benefits include:
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $15.2M
About
The SurgiVue platform enables both diagnostic and therapeutic interventions in a single procedure based on the endoscope industry’s smallest working diameter (2mm) with two working channels and flush ports, along with superior optics. Other key benefits include:
OphthalmologyMedical Devices
Funding History
2Total raised:$15.2M
Series A$12MMar 15, 2022
Seed$3.2MSep 15, 2020